Apr 24, 2024 4:05pm EDT ClearPoint Neuro Announces Initiation of Limited Market Release for the SmartFrame OR™ Stereotactic System
Apr 16, 2024 4:05pm EDT ClearPoint Neuro Congratulates its Partner AviadoBio on First Patient Treated in its ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations
Mar 19, 2024 8:07am EDT ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Application Submission to FDA for Upstaza™ as a Treatment for AADC Deficiency
Mar 11, 2024 8:00am EDT Journal of Neurosurgery Publication Demonstrates Distinct Advantages of ClearPoint Prism® Neuro Laser Therapy System
Mar 01, 2024 4:05pm EST ClearPoint Neuro to Announce Fourth Quarter and Full Year 2023 Results March 12, 2024
Feb 29, 2024 8:00am EST ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock